Quick Answer
Lactobacillus Plantarum Exercise Recovery Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Effect of Lactiplantibacillus plantarum GKK1 Supplementation on Exercise-Induced Fatigue, Muscle Damage, and Recovery in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled Trial
Key Takeaways
- 01Effect of Lactiplantibacillus plantarum GKK1 Supplementation on Exercise-Induced Fatigue, Muscle Damage, and Recovery in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled Trial [Lee M (2026)]
- 029 11 12 13 14 15 16 Prevotella Faecalibacterium Eubacterium Studies have shown that muscle mass and strength are strongly associated with the composition of GM (–). [Liu Yikai (2026)]
- 03For instance, recent systematic reviews have reported a significant association between reduced GM diversity and the occurrence of sarcopenia, and the reduction of some specific bacteria, such asandmight be associated with muscle loss (,). [Liu Yikai (2026)]
- 04Moreover, in patients with chronic diseases such as heart failure and chronic kidney disease, changes in the GM are also closely associated with sarcopenia, which further supporting the concept of the gut-muscle axis (,). [Liu Yikai (2026)]
The current Migaku evidence database contains 2 reusable source documents for Lactobacillus Plantarum Exercise Recovery Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Effect of Lactiplantibacillus plantarum GKK1 Supplementation on Exercise-Induced Fatigue, Muscle Damage, and Recovery in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled Trial [Lee M (2026); evidence level 2]
- 9 11 12 13 14 15 16 Prevotella Faecalibacterium Eubacterium Studies have shown that muscle mass and strength are strongly associated with the composition of GM (–). [Liu Yikai (2026); evidence level 3]
- For instance, recent systematic reviews have reported a significant association between reduced GM diversity and the occurrence of sarcopenia, and the reduction of some specific bacteria, such asandmight be associated with muscle loss (,). [Liu Yikai (2026); evidence level 3]
- Moreover, in patients with chronic diseases such as heart failure and chronic kidney disease, changes in the GM are also closely associated with sarcopenia, which further supporting the concept of the gut-muscle axis (,). [Liu Yikai (2026); evidence level 3]
- 1 2 3 Sarcopenia is an age-related condition characterized by generalized loss of skeletal muscle mass, strength, and physical function, which has a negative impact on the life quality and health status of elderly individuals. [Liu Yikai (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources